AM, K., L, Z., TR, P., CJ, B., Q, B., MR, W., & Y, F. (2024). From bench to bedside: The past, present and future of IL-21 immunotherapy. Medical oncology (Northwood, London, England), 41(7), 181. https://doi.org/10.1007/s12032-024-02404-7
Chicago Style (17th ed.) CitationAM, Kim, Zhao L, Patel TR, Bailey CJ, Bai Q, Wakefield MR, and Fang Y. "From Bench to Bedside: The Past, Present and Future of IL-21 Immunotherapy." Medical Oncology (Northwood, London, England) 41, no. 7 (2024): 181. https://doi.org/10.1007/s12032-024-02404-7.
MLA (9th ed.) CitationAM, Kim, et al. "From Bench to Bedside: The Past, Present and Future of IL-21 Immunotherapy." Medical Oncology (Northwood, London, England), vol. 41, no. 7, 2024, p. 181, https://doi.org/10.1007/s12032-024-02404-7.
Warning: These citations may not always be 100% accurate.
